3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
4
Head & Neck
2
Gynecologic
2
Thoracic
1
NET
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Neuroendocrine Tumors
26
Sarcoma
4
Carcinoma, Neuroendocrine
4
Prostatic Neoplasms
3
Pheochromocytoma
3
Paraganglioma
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma
3
Breast Neoplasms
3
Adenoma, Islet Cell
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Meningioma
2
Melanoma
2
Liver Neoplasms
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Gastro-enteropancreatic neuroendocrine tumor
2
Digestive System Neoplasms
2
Colonic Neoplasms
2
Colonic Diseases
2
Carcinoma, Renal Cell
2
Carcinoid Tumor
2
Adenocarcinoma
2
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Synovial
×
NET
×
30 days
×
Clear all
NCT06607692
2026-06-04
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled